With shares of American Express (NYSE:AXP) trading around $72, is AXP an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
American Express�is a global service company. Its principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses worldwide. The Company operates in four segments: U.S. Card Services, International Card Services, Global Commercial Services, and Global Network & Merchant Services. The way consumers and companies transact is constantly seeing incredible improvements which has led to amazing growth in this area. Consumers and businesses are seeing increasing worldwide growth and therefore, will continue to become dependent on the financial services provided by American Express.
T = Technicals on the Stock Chart are Strong
American Express stock has been exploding higher over the last several years. In fact, the stock is now trading at all-time high prices and seems to just keep surging higher. Analyzing the price trend and its strength can be done using key simple moving averages. What are the key moving averages? The 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, American Express is trading above its rising key averages which signal neutral to bullish price action in the near-term.
Top Heal Care Stocks To Invest In 2014: Advanced Braking Technology Ltd(ABV.AX)
Advanced Braking Technology Ltd. engages in designing, developing, manufacturing, and selling vehicle braking systems worldwide. The company provides the sealed integrated braking system (SIBS), which is an enclosed single-rotor high speed disc brake for on-road/off-road light commercial vehicle, automotive, and industrial applications; and engineering services, such as custom braking solutions. Advanced Braking Technology Ltd. was founded in 1999 and is headquartered in Osborne Park, Australia.
Top Heal Care Stocks To Invest In 2014: Aurium Resources Ltd(AGU.AX)
Aurium Resources Limited operates as a mineral exploration company in Australia. It focuses on iron ore deposits. The company has a joint venture agreement to explore for iron ore in the Robinson Range area of the Padbury-Bryah Basin in Western Australia. It also explores for uranium deposits in Australia. Aurium Resources Limited was incorporated in 2007 and is based in West Perth, Australia.
Top 5 Canadian Stocks For 2014: Hikma Pharmaceuticals(HIK.L)
Hikma Pharmaceuticals PLC engages in the development, manufacture, and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. It operates in three segments: Branded Pharmaceuticals, Injectable Pharmaceuticals, and Generic Pharmaceuticals. The Branded Pharmaceuticals segment offers 253 products in 485 dosage strengths and forms, which lie in the anti-infective, cardiovascular, central nervous system (CNS), and diabetes therapeutic areas. The Injectable Pharmaceuticals segment markets 120 branded and non-branded injectable products in 215 dosage strengths and forms with a focus on anti-infectives, musculoskeletal, cardiovascular, and oncological therapeutic areas. This segment provides powder, liquid, and lyophilized injectables. The Generic Pharmaceuticals segment offers 50 generic compounds in 117 dosage forms and strengths for various indications, such as analgesic, anti-infective, anti-infl ammatory, cardiovascular, CNS, respiratory, and hormonal and others in the form of tablets, capsules, solutions, and suspensions. This segment markets its products to chain stores, wholesalers, distributors, health systems, and governmental agencies. The company also manufacturers pharmaceutical packaging products; and conducts bio-equivalency studies. It has operations primarily in the United States, Europe, the Middle East, and north Africa. The company was founded in 1978 and is based in London, the United Kingdom.
Top Heal Care Stocks To Invest In 2014: Old Republic International Corporation(ORI)
Old Republic International Corporation, through its subsidiaries, provides various insurance and mortgage guaranty products in North America. The company operates in three segments: General Insurance, Mortgage Guaranty, and Title Insurance. The General Insurance segment provides liability insurance coverages to businesses, government, and other institutions in commercial construction, forest products, energy, general manufacturing, and financial services industries; and transportation, including trucking and general aviation industries. It provides various insurance products, such as automobile extended warranty, aviation, commercial automobile insurance, general liability, home warranty, inland marine, travel accident, and workers? compensation, as well as liability coverage for claims arising from the acts of owners or employees, and protection for the physical assets of businesses. This segment also offers financial indemnity products, such as consumer credit indemnity , errors and omissions/directors and officers, guaranteed asset protection, and surety, as well as bonds that cover the exposures for losses of monies, or debt and equity securities due to acts of employee dishonesty. The Mortgage Guaranty segment insures first mortgage loans, primarily on residential properties incorporating one-to-four family dwelling units to mortgage bankers, brokers, commercial banks, and savings institutions. The Title Insurance segment provides lenders' and owners' title insurance policies to real estate purchasers and investors based upon searches of the public records. It also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and services related to real estate transfers and loan transactions. Old Republic International Corporation markets its products directly, as well as through insurance agents and brokers. The company was founded in 1887 and is based in Chi cago, Illinois.
Advisors' Opinion:- [By Holly LaFon]
Prem Watsa is renowned for his long track record of outstanding returns using Buffett-style value investing through his worldwide insurance and reinsurance company, Toronto-based Fairfax Financial Holdings. His five-year cumulative is 176.4%, compared to 12.2% for the S&P 500. Most recently, he made headlines for making a large contrarian bet on Research In Motion (RIMM) and joining its board in his first activist investing foray. In the fourth quarter, he added to this position. He also added to his positions in Citigroup Inc. (C), Old Republic Corp. (ORI) and Johnson & Johnson (JNJ) and dramatically reduced one of his largest holdings, Dell (DELL). As a Ben Graham devotee, Watsa looks past short-term fluctuations in price to the underlying strength of a business. His stance on the economy, as of September and October 2011, was that he believed the U.S. was showing Depression-level interest rates and deficits, but he still liked some stocks and would hedge his exposure, he told CFA Institute Magazine.
- [By Ben Levisohn]
Its big day has also boosted other insurers. Radian Group (RDN) has risen 7.2% to $14.39, while Old Republic International (ORI) has advanced 2.1% to $15.24, Genworth Financial (GNW) is up 3.6% at $13.41 and MBIA Inc. (MBI) has jumped 4.3% to $10.76.
- [By Marc Bastow]
Insurance underwriting company Old Republic (ORI) raised its quarterly dividend 5.8% to 18 cents per share, payable on Dec. 16 to shareholders of record as of Dec. 4.
ORI Dividend Yield: 4.28% - [By Fredrik Arnold]
Ten Champion dogs that promised the biggest dividend yields into July included firms representing five of nine market sectors. The top stocks were three of five from the financial sector: Universal Health Realty Trust (UHT); Mercury General Corp. (MCY); Old Republic Int'l (ORI). The other two financial firms, HCP Inc., and United Bankshares Inc. (UBSI), placed sixth and eighth.
Top Heal Care Stocks To Invest In 2014: Life Technologies Corporation(LIFE)
Life Technologies Corporation operates as a global life sciences company. The company?s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company?s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporat ion also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. The company was founded in 1987 and is headquartered in Carlsbad, California.
Advisors' Opinion:- [By Rich Duprey]
Competition has been fierce among gene sequencing firms, but for the right players, business has been good. Life Technologies (NASDAQ: LIFE ) is being wooed by a number of suitors, including a bevy of private equity firms along with Thermo Fisher who all want access to Life's leading genetic sequencing equipment. Bids north of $11 billion are expected, which is said to be the biggest buyout in the space since Thermo Electron bought Fisher Scientific for almost $13 billion in 2006 to create Thermo Fisher.
No comments:
Post a Comment